NeuCyte

Accelerates neurological-disease therapy development by supplying human neural-cell tools and advanced screening platforms.

Buy

Buy NeuCyte shares

Sign up to view historical trading trends and place an offer.

Sell

Sell NeuCyte shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

NeuCyte, Inc. develops a proprietary human iPSC-derived neural-cell platform to support drug discovery for neurological disorders by providing differentiated neurons, astrocytes and microglia along with functional assays and high-throughput screening capabilities. It partners with biopharma to enable improved in vitro disease modeling, target validation and therapeutic-candidate screening focused on central-nervous-system diseases.a

Founded

2015

Headquarters

Sunnyvale, CA

Buy

Buy NeuCyte shares

Sign up to view historical trading trends and place an offer.

Sell

Sell NeuCyte shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Investors

Major NeuCyte investors

  • Shenzhen Cowin Capital

NeuCyte Valuations & Financials

Gain insights Into NeuCyte Stock Valuation & Share Prices

View real-time NPM data on NeuCyte stock including most recent valuation and historical share price information. Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.

Similar Companies

Explore companies

like NeuCyte

FAQ

Questions?

We have answers

Buy NeuCyte Stock

NeuCyte stock does not trade on public stock exchanges. NeuCyte stock is considered a private security and you need to be an accredited investor to trade shares. To invest in NeuCyte stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell NeuCyte Stock

NeuCyte Stock does not trade on public stock exchanges. In order to sell NeuCyte shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

NeuCyte Stock Price

NeuCyte does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view NeuCyte share price and other valuable private market data.

Read more about secondary market private company stock prices:

NeuCyte Stock Ticker Symbol

There is no ticker symbol for NeuCyte stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell NeuCyte Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell NeuCyte stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in NeuCyte Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in NeuCyte stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

NeuCyte Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

NeuCyte IPO

NeuCyte is a private company and has not had an IPO. There is currently no NeuCyte IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to NeuCyte IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.